Global Microbiome Sequencing Services Market Size, Share, Forecast Report, 2020-2027

The global Microbiome Sequencing Services market garnered revenue around USD XX Billion in 2019 and projected to reach USD XX Billion in 2027, with at a compound annual growth rate of XX% throughout the estimate period from 2020 to 2027.

The market of microbiome sequencing services is driven by factors such as rising demand for microbiome research, high investment in next-generation sequencing, and reduction in the cost of next-generation sequencing. For instance, according to the data published by the Wall Street Journal in 2016, venture funding in microbiome firms raised by 458.5% to USD 114.5 million from 2011 to 2015. Additionally, widening applications of microbiome sequencing and rise in the genome mapping programs are propelling the growth of the market.

On the other hand, the lack of skilled technicians, ethical and legal issues related to genome sequencing, and unaffordability of microbiome sequencing services in certain economies is thwarting the growth of microbiome sequencing services market to an extent.

Moreover, major companies in the market are involved in strategic collaborations to sustain their position in the market. For instance, in November 2017, Microbiome Therapeutics, LLC launched the first microbiome modulator. This product is a natural blend of prebiotics manufactured to help nurture and nourish beneficial microorganisms in the lower gut.

This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.

The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Microbiome Sequencing Services market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Microbiome Sequencing Services market growth.

The global Microbiome Sequencing Services market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.

Major manufacturers analysed under this study comprises:

• Baseclear B.V.

• Clinical Microbiomics A/S

• EPIBIOME

• Merieux Nutrisciences Corporations

• Metabiomics Corp.

• Microbiome Insights Inc.

• Microbiome Therapeutics, LLC.

• MR DNA

• Rancho Biosciences

• Second Genome

• Ubiome, Inc.

• Zymo Research Corp.

This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:

Global Microbiome Sequencing Services Market, by Technology

• Sequencing by Litigation (SBL)

• Sequencing by Synthesis (SBS)

• Short Gun Sequencing

• Targeted Gene Sequencing

• RNA Sequencing

• Others

Global Microbiome Sequencing Services Market, by Application

• Gastrointestinal Diseases

• Infectious Diseases

• CNS Diseases

• Oncology

• Others

Global Microbiome Sequencing Services Market, by End User

• Research and Academic Institutes

• Pharmaceutical and Biotechnology Companies

• Others

Regional Analysis and Forecast

Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:

• North America

 U.S.

 Canada

• Europe

 Germany

 U.K.

 Italy

 France

 Rest of EU

• Asia Pacific

 China

 India

 Japan

 Southeast Asia

 Rest of APAC

• Central & South America

 Brazil

 Argentina

 Rest of Central & South America

• Middle East and Africa

 UAE

 Saudi Arabia

 Rest of MEA